Market Shock as Trump Announces Major Tariffs on Pharmaceuticals

In a move that sent shockwaves through the European pharmaceutical sector, US President Donald Trump announced plans to impose significant tariffs on pharmaceuticals. This announcement led to an immediate downturn in the stocks of leading European pharmaceutical companies, including Sanofi, GSK, AstraZeneca, Roche, and Novartis.

Immediate Impact on European Pharma Stocks

By mid-morning CET, the financial markets reflected the anxiety of investors. Novartis AG and Roche Holding AG saw their stocks plummet by 7.03% and 5.80%, respectively. Similarly, Sanofi SA, AstraZeneca PLC, and GSK plc experienced significant drops, with their stocks falling by 5.64%, 6.27%, and 5.74% respectively.

Investor Concerns Over Global Market Implications

The proposed tariffs have raised concerns among investors about the potential ripple effects on the global pharmaceutical market. The announcement has sparked debates on the future of international trade relations and the pharmaceutical industry's stability.